Artivion AORT
NYSE AORT
$27.96 -0.86 (-2.98%)
As of: Aug 20, 2026 · 3:59 PM EDT

Artivion (AORT) Cash from Investing Activities (2010 - 2026)

Artivion's (AORT) quarterly Cash from Investing Activities came in at -$10.5 million in Q1 2026, down 188.7% YoY from $11.8 million in Q1 2025, and up 65.57% on a QoQ basis from -$30.5 million in Q4 2025.

Artivion (AORT) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Artivion (AORT) has 17 years of Cash from Investing Activities data on file, last reported at -$10.5 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 188.7% year-over-year to -$10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.9 million (down 73.33% YoY) and the FY2025 annual result came in at -$42.0 million, down 49.15% from the prior year.
  • Cash from Investing Activities advanced to -$10.5 million in Q1 2026, from -$30.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $7.1 million in Q2 2023 to a low of -$30.5 million in Q4 2025.
  • A 5-year average of -$5.4 million and a median of -$3.1 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 409.62% — and 2024, when it sank 414.46%.
  • Tracing AORT's Cash from Investing Activities over 5 years: stood at -$2.7 million in 2022, then retreated by 0.04% to -$2.7 million in 2023, then sank by 328.06% to -$11.4 million in 2024, then plunged by 167.02% to -$30.5 million in 2025, then soared by 65.57% to -$10.5 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$10.5 million (Q1 2026), -$30.5 million (Q4 2025), and -$4.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -673.00 Mn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn -639.00 Mn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn -193.20 Mn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn -22.08 Mn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn -108.50 Mn
10 Artivion 1.36 Bn 1.28 Bn 80.52 Mn -129.41 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -129.41 Mn
Jun 30, 2026 -129.41 Mn
Mar 31, 2026 -10.50 Mn
Mar 31, 2026 -10.50 Mn
Dec 31, 2025 -30.51 Mn
Dec 31, 2025 -30.51 Mn
Sep 30, 2025 -4.61 Mn
Sep 30, 2025 -4.61 Mn
Jun 30, 2025 -3.29 Mn
Jun 30, 2025 -3.29 Mn
Mar 31, 2025 -3.64 Mn
Mar 31, 2025 -3.64 Mn
Dec 31, 2024 -11.43 Mn
Dec 31, 2024 -11.43 Mn
Sep 30, 2024 -10.64 Mn
Sep 30, 2024 -10.64 Mn
Jun 30, 2024 -2.51 Mn
Jun 30, 2024 -2.51 Mn
Mar 31, 2024 -3.61 Mn
Mar 31, 2024 -3.61 Mn